Rapidly developing disruptive treatments for today’s most challenging diseases.
Location: United States, Ohio, Cincinnati
Investors 1
| Date | Name | Website |
| - | Rev1 Ventu... | rev1ventur... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 29.06.2021 | Eikonoklastes Closes Series A Funding | Eikonoklastes Therapeutics, a Cincinnati, Ohio-based preclinical stage biopharmaceutical company, ra... | finsmes.co... |